AIR Capital
AIR Capital, founded in 2021 and based in Buenos Aires, Argentina, is a venture capital investment firm that focuses on early-stage opportunities. The company is dedicated to empowering entrepreneurs who are working towards a future characterized by abundance, inclusion, and regeneration. AIR Capital invests in a diverse range of innovative sectors, including space technology, food technology, blockchain, metaverse, augmented reality, brain-computer interfaces, artificial intelligence, robotics, 3D printing, synthetic biology, biosensors, the internet of things, biomanufacturing, nanotechnology, and nuclear fission. Through its investments, AIR Capital aims to support transformative ideas and technologies that contribute to sustainable development and societal advancement.
Feedvax
Venture Round in 2024
Feedvax is an Argentine company founded in 2018 that specializes in developing oral vaccines for farmed fish, aiming to enhance animal production sustainably. The company has created a platform that delivers in-feed vaccines, beginning with a product targeting streptococcosis in tilapia, a widely farmed fish species. Feedvax's innovative approach allows for easy administration of vaccines through feed, providing an effective and environmentally safe alternative to antibiotics. This method not only protects fish from disease but also minimizes stress and potential contamination, offering a practical solution for fish producers seeking greater efficiency in aquaculture.
PunaBio
Seed Round in 2022
PunaBio is a Buenos Aires-based company that develops biological products aimed at enhancing agricultural productivity through environmentally friendly methods. By utilizing extremophile microorganisms, PunaBio focuses on improving crop nutrition, which contributes to increased yields and better crop quality. Their products are designed to enable farmers to cultivate crops on degraded soils and restore and enrich agricultural land sustainably. This approach not only helps improve farmers' productivity but also promotes sustainable agricultural practices.
Aplife Biotech
Venture Round in 2022
APLIFE BIOTECH is an Argentine biotech startup founded in 2018, based in Buenos Aires. The company focuses on developing innovative technologies for the high-throughput discovery of novel aptamers, which are essential for biosensors. APLIFE BIOTECH's platform specializes in manufacturing synthetic DNA-derived molecules and constructing large combinatorial libraries that facilitate the mass screening of significant biological molecules. This advanced biosensor technology aims to tackle global challenges in medical diagnostics by enabling the creation of novel aptamers for various applications, including proteomic diagnostic assays and therapeutic uses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.